LFB's recombinant anti-CD20 monoclonal antibody is granted orphan drug status in the USA for Chronic Lymphocytic Leukemia

06/08/2010

LFB Launches Process to buy out Austrian Plasma Collection Group to support its International Activity

22/06/2010

Sanofi-aventis and LFB industrial cooperation project in bio-production in France comes to fruition

22/04/2010

THALLION Pharmaceuticals and LFB BIOTECHNOLOGIES sign definitive agreement to develop and commercialize treatment for E.Coli infection

16/02/2010